Fosun International Ltd

Q3 2023 13F Holdings Report, Stock Holdings

Signature - Title
Angel Sze - Company Secretary
Location
Hong Kong
Holdings as of
September 30, 2023
Value $
$622M
Num holdings
74
Date filed
11/8/2023, 08:19 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included LANV, AMRX, NATR, BFLY, and MSFT.
Previous filing
Q2 2023 - Aug 14, 2023
Next filing
Q4 2023 - Feb 7, 2024
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2023 Q3 compared to 2023 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Angel Sze Company Secretary Hong Kong, Hong Kong 11/8/2023

Other Included Managers (2):

Num Name Location File Number
1 Fidelidade-Companhia de Seguros, S.A. Lisboa, Portugal 028-16288
2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai, China 028-18303